DICERNA PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
Dicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and James B. Weissman (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and John B. Green (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and Regina Paglia (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
AMENDMENT NO. 1 TO TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Transition and Separation Agreement (the “Amendment”) amends the Transition and Separation Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and Ralf Rosskamp (“you”) with a letter date of April 16, 2020 and an “Effective
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and Bob D. Brown (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and Robert Ciappenelli (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into on April 14, 2021 and amends the Employment Agreement between Dicerna Pharmaceuticals, Inc (the “Company”) and Ralf Rosskamp (the “Executive”) dated as of February 21, 2020 (the “Agreement”).
Royalty Purchase Agreement By and Between Dicerna Pharmaceuticals, inc. and RPI 2019 Intermediate Finance Trust Dated as of April 8, 2021Royalty Purchase Agreement • May 6th, 2021 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
